• Studies of antibodies and T cells in patients with Rheumatic disease.
  • Novel drug targets in patients with Rheumatic diseases; a role for IL-4R signaling.
  • Therapeutic antibody treatment for Cancer; a role for myeloid-derived suppressor cells and IL-4R signaling.
  • Custom CRISPR/Cas9 screens to identify drug targets in inflammatory diseases and Cancer.


Outline CRISPR screens:

crispr screen for homepage